BC can be classified into distinct subtypes based on unique molecular and histopathological characteristics, namely estrogen receptor-positive (ER +), human epithelial receptor-positive (HER +), and triple-negative breast cancer (TNBC). This evidence concerns the gene ESR1 and breast cancer.